Doctorglasses Chain Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	1,366	1,339	1,190	1,161	951.51	881.1
Other Revenue	21.14	21.14	12.68	14.63	10.72	6.37
Revenue	1,387	1,360	1,203	1,176	962.24	887.47
Revenue Growth (YoY)	12.52%	13.10%	2.29%	22.20%	8.43%	35.22%
Cost of Revenue	558.01	546.52	470.37	442.18	373.9	313.84
Gross Profit	829.42	813.87	732.44	733.69	588.34	573.63
Selling, General & Admin	635.03	630	592.02	564.92	498.69	454.23
Research & Development	1.95	2.01	3.08	4.67	-	-
Other Operating Expenses	6.41	5.86	4.15	4.99	1.91	2.64
Operating Expenses	643.35	638.2	599.58	575.31	501.06	457.35
Operating Income	186.08	175.66	132.86	158.38	87.28	116.28
Interest Expense	-7.15	-7.46	-8.61	-7.69	-9.02	-9.09
Interest & Investment Income	12.22	13.04	16.3	15.24	9.43	9.4
Currency Exchange Gain (Loss)	-1.19	-1.19	-0.77	0.52	0.31	0.33
Other Non Operating Income (Expenses)	-5.53	-4.52	-4.61	-3.77	-3.44	-3.5
EBT Excluding Unusual Items	184.42	175.53	135.16	162.68	84.57	113.42
Impairment of Goodwill	-	-	-12.14	-5.3	-	-
Gain (Loss) on Sale of Investments	28.03	24.39	2.21	4.58	-0.83	-0.39
Gain (Loss) on Sale of Assets	0.83	0.52	2.35	0.88	2.26	0.59
Asset Writedown	-9.58	-9.51	-4.04	-0.14	-0.1	-0.1
Other Unusual Items	1.06	1.06	5.57	1.44	6.94	7.71
Pretax Income	204.76	191.99	129.12	164.13	92.84	121.24
Income Tax Expense	40.75	38.3	27.8	32.37	18.4	26.74
Earnings From Continuing Operations	164.01	153.69	101.32	131.76	74.44	94.5
Minority Interest in Earnings	-5.68	-5.08	2.31	-3.69	1.37	0.28
Net Income	158.33	148.61	103.63	128.06	75.81	94.78
Net Income to Common	158.33	148.61	103.63	128.06	75.81	94.78
Net Income Growth	45.57%	43.40%	-19.08%	68.93%	-20.02%	37.02%
Shares Outstanding (Basic)	316	320	315	315	307	308
Shares Outstanding (Diluted)	321	320	315	315	314	314
Shares Change (YoY)	1.85%	1.49%	0.13%	0.46%	-0.04%	2.15%
EPS (Basic)	0.50	0.46	0.33	0.41	0.25	0.31
EPS (Diluted)	0.49	0.46	0.33	0.41	0.24	0.30
EPS Growth	42.91%	41.30%	-19.18%	68.16%	-19.99%	34.13%
Free Cash Flow	269.92	276.29	249.53	259.34	182.13	170.83
Free Cash Flow Per Share	0.84	0.86	0.79	0.82	0.58	0.55
Dividend Per Share	1.929	1.929	0.148	0.330	0.165	0.275
Dividend Growth	1199.60%	1199.60%	-54.99%	100.06%	-40.01%	42.85%
Gross Margin	59.78%	59.83%	60.89%	62.40%	61.14%	64.64%
Operating Margin	13.41%	12.91%	11.05%	13.47%	9.07%	13.10%
Profit Margin	11.41%	10.92%	8.62%	10.89%	7.88%	10.68%
Free Cash Flow Margin	19.45%	20.31%	20.75%	22.05%	18.93%	19.25%
EBITDA	190.39	182.07	147.62	172.3	97.85	125.52
EBITDA Margin	13.72%	13.38%	12.27%	14.65%	10.17%	14.14%
D&A For EBITDA	4.31	6.4	14.76	13.92	10.57	9.23
EBIT	186.08	175.66	132.86	158.38	87.28	116.28
EBIT Margin	13.41%	12.91%	11.05%	13.47%	9.07%	13.10%
Effective Tax Rate	19.90%	19.95%	21.53%	19.72%	19.82%	22.05%
Revenue as Reported	1,387	1,360	1,203	1,176	962.24	887.47
Advertising Expenses	-	9.28	7.69	6.98	4.23	2.72